Physician profile

Monte Schmalhaus

Foot & Ankle Surgery · Mission Viejo, CA

NPI 1932761822

$9,578.93

in general payments reported to CMS, 2019-2025

37 companies · $3,067 in 2025

The $3,067 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,051.38
Travel and Lodging$4,166.13
Long Term Medical Supply Or Device Loan$213.14

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Paragon 28, INC. $2,311.12 2023-2024 Monkey Rings, Apex 3d
Integra Lifesciences Corporation $1,604.79 2023-2025 Integra, Primatrix, Integra Dermal Regeneration Template
Saxum Surgical, INC. $840.57 2023-2025
Arthrex, INC. $696.40 2025
Stryker Corporation $458.77 2023-2025 Augment Injectable, Prophecy, Citrefix
Linvatec Corporation $458.20 2025 Quantum, Biobrace 23mm
Treace Medical Concepts, INC. $414.97 2024-2025
Inari Medical, INC. $368.42 2023-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Kerecis Limited $304.58 2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose
Evolution Surgical, INC $302.53 2022-2023
Koya Medical, INC. $295.02 2023 Dayspring
Surgenex LLC $187.62 2025 Renograft, Pellograft, Surmatrix
Alafair Biosciences, INC. $177.25 2024 Versawrap
Exactech, INC. $136.68 2024
Shionogi INC $123.86 2024 Fetroja
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Fusion Orthopedics USA, LLC $102.71 2023
Organogenesis INC. $95.94 2024
Paratek Pharmaceuticals, INC. $58.67 2024-2025 Nuzyra
Smith+Nephew, INC. $58.47 2024-2025 Bone Anchors With Arthroscopic Delivery System, Q-Fix, Footprint
Tactile Systems Technology INC $57.57 2023-2025 Flexitouch Plus, Nimbl, Entre Plus
Davol INC. $53.29 2024-2025 Arista Ah Flexitip, Arista
Curonix LLC $50.71 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Biotissue Holdings INC. $45.80 2024
Depuy Synthes Sales INC. $41.86 2024
Medtronic, INC. $36.66 2024 Intellis Adaptivestim
Ani Pharmaceuticals, INC. $33.16 2025 Purified Cortrophin Gel
Abbvie INC. $32.54 2023 Dalvance
Bioventus LLC $31.85 2024 Bonescalpel & Sonicone (O.R.)
Next Science LLC $31.37 2025 Xperience, Blastx
Molnlycke Health Care US, LLC $27.18 2025 Exufiber, Mepilex Transfer Ag, Exufiber Ag+
Corcept Therapeutics $26.90 2025 Korlym
Lifenet Health $22.58 2025 Theragenesis Wound Matrix
Averitas Pharma INC. $22.15 2023 Qutenza
Djo, LLC $21.56 2024 Aircast
Advanced Oxygen Therapy INC. $16.89 2025 Topical Oxygen Chamber For Extremities
Reprise Biomedical, INC. $16.75 2024 Miro3d
Mimedx Group, INC. $13.54 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Monte Schmalhaus

$9,578.93

in general payments reported 2019-2025

Years
2022-2025
Top company
Paragon 28, INC.
Context
The $3,067 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/11423736/monte-schmalhaus

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.